期刊文献+

HA和IGF-1检测对甲状腺相关性眼病活动度的评价 被引量:7

Evaluationon Activity of Thyroid-associate Ophthalmopathy with Serum Hyaluronic Acid and Insulin-like Growth Factor-1
下载PDF
导出
摘要 目的 分析甲状腺相关眼病(TAO)患者血清透明质酸(HA)和胰岛素样生长因子(IGF-1)水平,为甲状腺相关眼病活动度评价提供实验室指标.方法 TAO患者55例且甲状腺功能控制在正常范围,根据临床活动度评分(CAS)分为活动期组(CAS≥4分,共30例)和静止期组(CAS<4分,共25例),根据NOSPECS对TAO患者分级,本组病例均为2~4级;无TAO正常对照组35例.采用放射免疫法测定血清HA和IGF-1浓度.应用受试者工作特性曲线(ROC曲线)评价HA、IGF-1对TAO患者活动度的诊断价值.结果 ①TAO活动期组患者血清HA、IGF-1水平明显高于静止期组及正常对照组(P<0.01);活动期HA、IGF-1分别是静止期组患者的2.38倍、2.82倍,是正常对照组的2.80倍、3.09倍.②HA、IGF-1的水平变化随TAO的分级程度增加而升高,差异均有统计学意义(P<0.05).③TAO患者的HA、IGF-1在ROC曲线下面积分别为0.933,0.927.HA、IGF-1诊断TAO活动度的平均灵敏度、特异度分别是93.8%、86.1%、91.6%、84.1%.结论 血清HA和IGF-1水平与TAO活动度有关,参与TAO的发生.HA和IGF-1能够作为TAO活动度的实验室评价指标. Objective To detect the level of serum hyaluronic acid (HA) and insulin-like growth factor -1 (IGF-1 ) in thyroid-associate ophthalmopathy (TAO) patients and to provide experimental evaluation of the activity of TAO. Methods 55 cases of OTA patients with normal thyroid functions were involved. The patients based on Clinical Activity Score (CAS) were classified to activity stage group (CAS≥4,30 cases) and resting stage group (CAS 〈4,25 eases). 36 people without TAO and thyroid-associated disease were enrolled into the control group. The levels of serum HA and IGF-1 in patients and healthy controls were measured by radioimmunoassay. The receiver operator characteristic curve was used to evaluate the diagnostic value for the activity of thyroid- associate ophthalmopathy. Results The serum HA and IGF- 1 levels in active stage group were significantly higher than that of resting stage group and control group (P 〈 0.01 ). The levels HA and IGF- 1 in active stage group were 2.38 and 2.82 times higher than that of in resting stage group, and 2.80 and 3.09 times higher than that of in the control group respectively. The serum HA and IGF-1 levels were increased with the increase of severity of TAO (P 〈 0.05 ). The receiver operator characteristic curve ( ROC ) showed that the area under curve of HA and IGF- 1 from TAO patients were 0.933 and 0.927 respectively. The average sensitivity and specificity of HA and IGF-1 for diagnosis the activity of TAO were 93.8% ,86. 1% ,91.6 % and 84. 1% respectively. Conclusion The serum levels of HA and IGF- 1 are correlated with the activity of thyroid associatedophthalmopathy. The serum ophthalmopathy. The serum activity of TAO. HA and IGF-1 might be HA and IGF-1 could be used involved in the development of thyroid-associated as index for providing experimental evaluation of the
作者 何伟 刘英
出处 《标记免疫分析与临床》 CAS 2014年第4期401-404,共4页 Labeled Immunoassays and Clinical Medicine
关键词 甲状腺相关眼病 血清透明质酸 胰岛素样生长因子 活动度评价指标 ROC曲线 Thyroid- associated ophthalmopathy Serum hyaluronic acid Insulin- like growth factor- 1 Activity index Receiver operator characteristic curve
  • 相关文献

参考文献6

  • 1Prabhakar B S,Bahn R S,Smith T J,et al.Current perspectve on the pathogenesis ofGraves' disease and ophthalmopathy.Endocr Rev,2003,24(6):802-835.
  • 2Pappa A,Jackson P,Stone J,et al.An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy.Eye(Lond),1998,12(2):237-244.
  • 3闵寒毅,刘熙朴,胡天圣,连琏.氨基葡聚糖:Graves眼病活动度的指标[J].眼科,2002,11(5):267-269. 被引量:8
  • 4Martins J R,Furlanetto R P,Oliveira L M,et al.Comparison of practical methods for urinaryglycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves' ophthalmopathy.Clin Endocrinol (Oxf),2004,60 (6):726-733.
  • 5Smith T J,Hoa N.Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen,insulin-like growth factor-I receptor.J Clin Endocrinol Metab,2004,89(10):5076-5080.
  • 6EI-Kaissi S,Frauman A G,Wall J R.Thyroid-associated ophthalmopathy:a practical guide to classification,natural history and management.Intern Med J,2004,34(8):482-491.

二级参考文献9

  • 1[1]Rececca SB,Armin EH.Pathogenesis of Graves ophthalmopathy[J].N Eng J Med,2000,329:1468-1475.
  • 2[2]Kahaly G,Schuler AC,Sewell G,et al.Urinary glycosaminoglycans in Graves ophthalmopathy[J].Clin Endocrinol,1990,33:35-44.
  • 3[3]Bitter T,Muir HM.A modified uronic acid carvazole reaction[J].Analytical biochem,1963,4:330-334.
  • 4[4]Pennock CA.A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion and the diagnosis of mucopolysaccharidoses[J].J Clin Path,1984,29:111-123.
  • 5[5]Wegelius O,Asboe-Hansen G,Lamberg BA.Retrobulbar connective tissue changes in malignant exophthalmos[J].Acta Endocrinologica,1957,25:452-456.
  • 6[6]Ursu H,Dumitrescu C,Bartoc R,et al.Determination of mucopolysaccharides in Graves disease[J].Endocrinology,1984,22:277-282.
  • 7[7]Sisson JC,Kirchick H,Kothary P.Inhibition of glycosaminoglycan prodution in retrobulbar fibroblast cultures by ethacrynic acid and hydrocortisone[J].J Clin Endocrinol and Metab,1974,38:777-782.
  • 8[8]Smith TJ.Dexamethasone regulation of glycosaminoglycan synthesis in cultrued human skin fibriblasts[J].J Clin Invest,1984,74:2157-2163.
  • 9[9]Glinoer D,Etienne-Decerf J,Schrooven M,et al.Beneficial effects of intensive plasma exchanges followed by immurosuppressive therapy in severe Gravesophthalmopathy[J].Acta Endocrinol,1986,111:30-38.

共引文献7

同被引文献103

  • 1朱丹,李良长,欧阳丽,黄蓉.电针联合曲安奈德治疗甲状腺相关眼病上睑退缩临床观察[J].湖北中医杂志,2020,42(11):36-38. 被引量:4
  • 2叶小珍,王坚,胡兰萍,顾萍,李洁,邵加庆,王燕燕.碱性成纤维细胞生长因子-2在Graves眼病发病机制中的作用[J].中国全科医学,2009,12(16):1530-1531. 被引量:1
  • 3张明发,沈雅琴.浙贝母药理研究进展[J].上海医药,2007,28(10):459-461. 被引量:141
  • 4Pawlowski P, Mysliwiec J, Staslak-I3armuta A, et al. Increased percentage of L-selectin+ and ICAM 1+ peripheral blood CD4+ / CD8+ T cells in active Graves' ophrhalmopathy [J]. Folia Histochem Cytobiol,2009,47(1) :29 33.
  • 5Wei H, Guan M, Qin Y, et al. Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy[J]. Endocr J, 2014, 61 (11): 1087 1092.
  • 6Vondrichova T, de Capretz A, Parikh H, et al. COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy[J~. Thyroid, 2007. 17(6) ~511 517.
  • 7Huang D, Xu N, Song Y, et al. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathyEJ~. Graefes Arch Clin Exp Ophthalmol, 2012,250(4) : 619-625.
  • 8Cai K, Wei R. Interleukin-7 expression in tears and orbital tissues of patients with Graves' ophthalmopathy [ J ~. Endocrine,2013,44(1) :140 144.
  • 9Ujhelyi B, Gogolak P, Erdei A, et al. Graves' orbitopathy results in profound changes in tear composition~ a study o~ plasminogen activator inhibitor 1 and seven cytokines [J]. Thyroid, 2012,22 (4) : 407 441.
  • 10Ruffilli I, Ferrari SM, Colaci M, et al. IP 10 in autoimmune thyroiditis[J]. Horm Metab Res,2014,46(9) :597-602.

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部